These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8831748)

  • 1. [Five cases of myelodysplastic syndrome treated with cytarabine ocfosfate].
    Nishi T; Funasako M; Hata N; Andoh K; Itoh Y; Ono H; Itoh K; Sato Y; Sato H; Taniji M; Nakai S; Ueda A; Fujimoto H; Ohata M
    Gan To Kagaku Ryoho; 1996 Sep; 23(10):1331-4. PubMed ID: 8831748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of acute myeloid leukemia and myelodysplastic syndrome with orally administered cytarabine ocfosfate and granulocyte colony-stimulating factor.
    Okumura H; Yoshida T; Takamatsu H; Katoh T; Murashima M; Watanabe A; Yamauchi H; Matano S; Chuhjo T; Takeshima M; Kaya H; Ohtake S; Nakamura S; Matsuda T
    Int J Hematol; 1997 Apr; 65(3):263-8. PubMed ID: 9114597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Complete remission by cytarabine ocfosfate plus G-CSF therapy in a patient with hypoplastic RAEB-T].
    Kadowaki I; Sasaki O; Sasaki T; Ishizawa K; Kimura J; Nomura J; Furuyama K; Harigae H; Shishido T; Okuda M
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):145-7. PubMed ID: 7529978
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of oral cytarabine ocfosfate and etoposide in the treatment of elderly patients with higher-risk myelodysplastic syndromes compared to that in elderly acute myeloid leukemia patients.
    Horikoshi A; Iriyama N; Hirabayashi Y; Kodaira H; Matsukawa Y; Uchino Y; Takahashi H; Hatta Y; Takeuchi J; Kobayashi S; Miura K
    Chemotherapy; 2013; 59(2):152-8. PubMed ID: 24080768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of refractory hematologic malignancies by combination of cytarabine ocfosfate and etoposide].
    Kiyama Y; Suzuki G; Masauzi N; Ohizumi H; Kobayashi N; Ogasawara M; Naohara T; Saito M; Higa T; Kasai M
    Gan To Kagaku Ryoho; 1996 Oct; 23(12):1717-20. PubMed ID: 8886052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A pharmacokinetic study of the value of oral cytarabine ocfosfate in the treatment of hematological malignancies].
    Ueda Y; Mori S; Ito T; Maesako Y; Konishi H; Yagiri Y
    Rinsho Ketsueki; 1998 May; 39(5):348-54. PubMed ID: 9637884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Successful treatment of myelodysplastic syndrome with cytarabine ocfosfate].
    Arai T; Narimiya S; Hayakawa K; Takaya T; Toshima S; Araki M; Uchida A; Yoshimi N; Shibuya C; Yasuda Y
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):1085-8. PubMed ID: 8002627
    [No Abstract]   [Full Text] [Related]  

  • 8. [Successful treatment of acute myelogenous leukemia in an elderly patient with cytarabine ocfosfate].
    Inaba T; Shimazaki C; Tatsumi T; Yamagata N; Hirata T; Goto H; Fujita N; Nakagawa M; Fujita N; Miyazaki S
    Gan To Kagaku Ryoho; 1994 Mar; 21(4):535-8. PubMed ID: 8129396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A combination chemotherapy with cytarabine ocfosfate, low dose etoposide, and G-CSF for the treatment of high risk MDS (RAEB, RAEBt)--a pilot study].
    Hara M; Kojima K; Azuma T; Narumi H; Shinagawa K
    Rinsho Ketsueki; 1998 Apr; 39(4):314-6. PubMed ID: 9597900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful treatment of refractory anemia with excess of blasts in transformation with cytarabine ocfosfate].
    Takeuchi M; Kojima K; Takaba S; Isokawa M; Tanimizu M; Kimura F; Ohmoto E; Harada M
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):141-4. PubMed ID: 7826071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Refractory anemia with excess myeloblast in transformation induced remission by combined oral administration of cytarabine ocfosfate and 6-mercaptopurine].
    Fukumi S; Mizorogi F; Matsuo A; Sato H; Abe T
    Gan To Kagaku Ryoho; 1995 Jun; 22(7):945-8. PubMed ID: 7794001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A severe hepatic disorder with myelodysplastic syndrome, treated with cytarabine ocfosfate, in a dog.
    Ide K; Momoi Y; Minegishi M; Sekiguchi M; Konno K; Iwasaki T
    Aust Vet J; 2003; 81(1-2):47-9. PubMed ID: 15084010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma concentration of cytosine arabinoside (Ara-C) in the elderly patients with hematological malignancy treated by Ara-C or cytarabine ocfosfate (SPAC)].
    Tsutsumi H; Kumakawa T; Hirai M; Kikukawa M; Arie Y; Mori M; Kodo H; Nakamura N; Murai Y; Mizutani R
    Nihon Ronen Igakkai Zasshi; 1995 Mar; 32(3):190-4. PubMed ID: 7596061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Low-dose cytarabine ocfosfate therapy in an elderly acute myelogenous leukemia].
    Hamaoka R; Jozaki K; Amano T; Itoh H; Imai Y; Nishikawa M; Kurokawa M; Yonezawa T; Chinen Y
    Gan To Kagaku Ryoho; 1995 May; 22(6):819-22. PubMed ID: 7755392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Successful treatment of acute myelomonocytic leukemia developed from MDS with cytarabine ocfosfate (SPAC)].
    Wake A; Takazawa A; Serino Y; Tonai S; Nakanishi M; Murakami S; Ogawa R; Nagata K; Mori N; Nakata K
    Gan To Kagaku Ryoho; 1995 Feb; 22(3):395-8. PubMed ID: 7880111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of oral cytarabine ocfosfate and etoposide in the treatment of refractory and elderly AML patients.
    Horikoshi A; Takei K; Hosokawa Y; Sawada S
    Int J Hematol; 2008 Mar; 87(2):118-125. PubMed ID: 18228114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral administration of cytarabine ocfosfate and ondansetron hydrochloride in patients with acute myeloid leukemia who can not be treated with intensive chemotherapy:--attempt to make their quality of life better].
    Yano K; Matsui H; Fujisawa S
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):427-30. PubMed ID: 9492840
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of cytarabine ocfosfate on colony-stimulating factor in myelodysplastic syndrome with monosomy 7].
    Masumoto A; Ohbayashi Y; Kawada H; Arimori K; Sasao T; Ogawa Y; Fujiwara H; Fukuda R; Watanabe S; Umeda Y
    Rinsho Ketsueki; 1994 Jun; 35(6):603-8. PubMed ID: 7521405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypoplastic leukemia successfully treated by oral administration with cytarabine ocfosfate].
    Okuyama Y; Kitazume K; Iwabe K; Usuki K; Urabe A
    Rinsho Ketsueki; 1994 Jun; 35(6):593-7. PubMed ID: 8078195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow cytogenetic complete remission achieved by interferon-alpha plus cytarabine ocfosfate therapy in a patient with chronic myelogenous leukemia during extramedullary blast crisis.
    Gotoh A; Miyazawa K; Uchida Y; Sashida G; Kawakubo K; Kuriyama Y; Ohyashiki K
    Int J Hematol; 2002 Feb; 75(2):191-4. PubMed ID: 11939268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.